SLS Competitors & Alternatives
Compare Sellas Life Sciences Group Inc with similar stocks in the same industry
Biotechnology
SLS
Main Stock$11.28
Tradestie Score
46
Market Cap
$211.22M
Revenue Growth
-0.8%
Analyst Upside
+188.1%
Top Competitors
223 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CDTX
Cidara Therapeutics, Inc.
|
$221.38
|
$2.44B | - | 50 | Compare |
|
BEAM
Beam Therapeutics Inc. Common Stock
|
$24.22
|
$2.44B | - | 58 | Compare |
|
TARS
Tarsus Pharmaceuticals, Inc. Common Stock
|
$72.18
|
$2.42B | - | 62 | Compare |
|
BLTE
Belite Bio, Inc American Depositary Shares
|
$149.93
|
$2.41B | - | 69 | Compare |
|
IDYA
IDEAYA Biosciences, Inc. Common Stock
|
$35.57
|
$2.40B | - | 62 | Compare |
|
FOLD
Amicus Therapeutics, Inc
|
$14.49
|
$2.38B | - | 52 | Compare |
|
ARQT
Arcutis Biotherapeutics, Inc. Common Stock
|
$32.09
|
$2.37B | 142.7 | 41 | Compare |
|
APGE
Apogee Therapeutics, Inc. Common Stock
|
$135.07
|
$2.35B | - | 54 | Compare |
|
IBRX
ImmunityBio, Inc. Common Stock
|
$8.06
|
$2.34B | - | 39 | Compare |
|
IRON
Disc Medicine, Inc. Common Stock
|
$75.11
|
$2.33B | - | 40 | Compare |
More SLS Analysis
Data updated: Oct 22, 2026 | Industry: Biotechnology (SIC 2834)
223 stocks in this industry